Nika Danial received her B.S. in biological sciences from Stanford University and her Ph.D. from Columbia University. She trained with the late Stanley J. Korsmeyer as a post doctoral fellow at the Dana-Farber Cancer Institute, where she identified a novel role for the BCL-2 family protein BAD in glucose metabolism independent of its apoptotic function. She became a faculty member at the Dana-Farber Cancer Institute and Harvard Medical School in 2005. Her lab focuses on deciphering how the cells’ capacity to process difference carbon substrates modulates cellular stress responses, including, but not limited to cellular life/death decisions.
« Go Back